A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Sevoflurane
Vorapaxar
The risk or severity of adverse effects can be increased when Vorapaxar is combined with Tauroursodeoxycholic acid.
Sevoflurane
Icosapent ethyl
The risk or severity of adverse effects can be increased when Icosapent ethyl is combined with Tauroursodeoxycholic acid.
Sevoflurane
Triflusal
The risk or severity of adverse effects can be increased when Triflusal is combined with Tauroursodeoxycholic acid.
Sevoflurane
Tranilast
The risk or severity of adverse effects can be increased when Tranilast is combined with Tauroursodeoxycholic acid.
Sevoflurane
Cangrelor
The risk or severity of adverse effects can be increased when Cangrelor is combined with Tauroursodeoxycholic acid.
Sevoflurane
Prasugrel
The risk or severity of adverse effects can be increased when Prasugrel is combined with Tauroursodeoxycholic acid.
Sevoflurane
Caplacizumab
The risk or severity of adverse effects can be increased when Caplacizumab is combined with Tauroursodeoxycholic acid.
Sevoflurane
Andrographolide
The risk or severity of adverse effects can be increased when Andrographolide is combined with Tauroursodeoxycholic acid.
Sevoflurane
Ibudilast
The risk or severity of adverse effects can be increased when Ibudilast is combined with Tauroursodeoxycholic acid.
Sevoflurane
Beraprost
The risk or severity of adverse effects can be increased when Beraprost is combined with Tauroursodeoxycholic acid.
Sevoflurane
Defibrotide
The risk or severity of adverse effects can be increased when Defibrotide is combined with Tauroursodeoxycholic acid.
Sevoflurane
Tesmilifene
The risk or severity of adverse effects can be increased when Tesmilifene is combined with Tauroursodeoxycholic acid.
Sevoflurane
Nimesulide
The risk or severity of adverse effects can be increased when Nimesulide is combined with Tauroursodeoxycholic acid.
Sevoflurane
Resveratrol
The risk or severity of adverse effects can be increased when Resveratrol is combined with Tauroursodeoxycholic acid.
Sevoflurane
Epoprostenol
The risk or severity of adverse effects can be increased when Epoprostenol is combined with Tauroursodeoxycholic acid.
Sevoflurane
Sevoflurane
The risk or severity of adverse effects can be increased when Sevoflurane is combined with Tauroursodeoxycholic acid.
Sevoflurane
Reviparin
The risk or severity of bleeding and bruising can be increased when Reviparin is combined with Tauroursodeoxycholic acid.
Sevoflurane
Troxerutin
The risk or severity of bleeding and bruising can be increased when Troxerutin is combined with Tauroursodeoxycholic acid.
Sevoflurane
Zinc citrate
The risk or severity of bleeding and bruising can be increased when Zinc citrate is combined with Tauroursodeoxycholic acid.
Sevoflurane
Dabigatran
The risk or severity of bleeding and bruising can be increased when Dabigatran is combined with Tauroursodeoxycholic acid.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3